http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200913987-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ef5401e6b556cb3204b62a2601903f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06
filingDate 2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3935d3fcf746125aed099764836255df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45756d5cb1b49f4241e72a5674acb22f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c10c1b2817418602a6f79cfa0506bcbd
publicationDate 2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200913987-A
titleOfInvention Extract of Myrothecium sp. mycelium used to inhibit growth of tumor cell
abstract The present invention relates to an extract of Myrothecium sp. mycelium used to inhibit growth of tumor cell, particularly relating to compounds of verrucarin A and verrucarin J segregated from the Myrothecium sp. Mycelium which can effectively inhibit growth of cells of the hepatoma, lung cancer, and prostate cancer. In the present invention, the compounds of verrucarin A and verrucarin J can be applied in inhibiting growths of Hep3B and HepG2 of the human hepatoma cells, A549 of the human lung cancer cell, and LNCaP and DU-145 of the human prostate cancer cells, and simultaneously can be used in the medicament composition of inhibiting growth of cells of the hepatoma, lung cancer, and prostate cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112725362-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112725362-A
priorityDate 2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18695655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12444784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152772152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450056257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422603538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID97441
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID168345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458399228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1756106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6444374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450282151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582416
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID168345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437363
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12242
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426109569
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1756106
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID97441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73971

Total number of triples: 50.